Development of effective tumor immunotherapy using a novel dendritic cell–targeting Toll-like receptor ligand

Although dendritic cell (DC)-based immunotherapy shows little toxicity, improvements should be necessary to obtain satisfactory clinical outcome. Using interferon-gamma injection along with DCs, we previously obtained significant clinical responses against small or early stage malignant tumors in do...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: De Silva, Nadeeka H., Akazawa, Takashi, Wijewardana, Viskam, Inoue, Norimitsu, Oyamada, Maremichi, Ohta, Atsuko, Tachibana, Yuki, Wijesekera, Daluthgamage Patsy H., Kuwamura, Mitsuru, Nishizawa, Yasuko, Itoh, Kazuyuki, Izawa, Takeshi, Hatoya, Shingo, Hasegawa, Tetsuya, Yamate, Jyoji, Inaba, Toshio, Sugiura, Kikuya
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5708771/
https://ncbi.nlm.nih.gov/pubmed/29190690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0188738
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados